fda compounding semaglutide enforcement november 2025 Compound versions of GLP-1 drugs for weight loss halted by Compounded "semaglutide" is not FDA-approved

A, Cumulative food intake (grams) up to 8 h after an acute ICV injection of OXM (0.3, 1, 3, or 10 nmol)

Starting at $495 Cagrilintide May help support appetite regulation and body composition as part of a provider-guided weight loss plan

In a letter dated March 5, the FDA criticized Novo Nordisk for serious violations related to the reporting of possible side effects linked to semaglutide, the active ingredient in Ozempic and Wegovy

Weight loss in T1D may be more modest than in type 2 diabetes

That helps explain the numerous health improvements that have turned up in the past few years that dont have an obvious connection to digestion, weight or metabolism